COARTEM 20 mg /120 mg artemether/lumefantrine 20 mg/120 mg dispersible tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

artemether, Quantity: 20 mg; lumefantrine, Quantity: 120 mg

Available from:

Novartis Pharmaceuticals Australia Pty Ltd

INN (International Name):

Artemether,Lumefantrine

Pharmaceutical form:

Tablet, dispersible

Composition:

Excipient Ingredients: microcrystalline cellulose; croscarmellose sodium; crospovidone; saccharin sodium; hypromellose; magnesium stearate; polysorbate 80; colloidal anhydrous silica; Flavour

Administration route:

Oral

Units in package:

12 tablets, 24 tablets, 18 tablets, 180 tablets, 6 tablets, 360 tablets, 540 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Coartem Dispersible tablet is indicated for the treatment of acute, uncomplicated malaria due to Plasmodium falciparum in children and infants weighing between 5kg and less than 35kg.

Product summary:

Visual Identification: Yellow, round, flat tablets with a beveled edge, debossed with "CD" on one side and "NVR" on the reverse side; Container Type: Blister Pack; Container Material: PVC/PVDC/PE; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Authorization status:

Registered

Authorization date:

2010-07-09